Kilitch Drugs (India) Ltd.
KILITCH Share PricePharmaceuticals & Drugs
₹341.75
0.9 (0.3%)
As on December 4, 2025
Exchange Scrips: BSE524500NSEKILITCHISININE729D01010
Market Cap ₹ 598 Cr
P/E Ratio 21.03
Dividend Yield N/A
Performance
Market performance
Open342.55
High343
Volumes8,388
Prev341.75
Low337.5
As on2025-12-04
Historical performance
1 Year High500
3 Year High500
5 Year High500
1 Year Low293.53
3 Year Low122.32
5 Year Low77.36
Fundamentals
Company Valuation
Market Cap (₹Cr)
598
Face Value (₹)
10
P/E Ratio
21.03
Dividend Yield
N/A
Investment Returns
1 Year
4.4%
3 Years
116.1%
5 Years
272.3%
10 Years
649.4%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 342.5 | Bearish |
| 10-DMA | 350.48 | Bearish |
| 20-DMA | 357.09 | Bearish |
| 50-DMA | 362.44 | Bearish |
| 100-DMA | 385.27 | Bearish |
| 200-DMA | 380.8 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 4 | 4 |
| Public Investors | 10925 | 10375 | 9745 | 10135 | 9916 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 21.03.
- 3Y Stock Price CAGR of the stock is 29.1.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹429 Million.
- The company generated revenue of ₹1983 Million in the previous financial year.
Kilitch Drugs (India) Ltd.
341.750.9 (0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1030783.2
No. of Shares: 3016 (Approx)
Performance:3.1%
P/L: ₹30783.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
